Analyst Reco. Iqvia Holdings Inc.

Equities

IQV

US46266C1053

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 04:00:02 2024-12-05 pm EST			5-day change	1st Jan Change
199.93 ^USD	-1.59%		-0.74%	-13.59%

Dec. 04	HSBC Adjusts Price Target on IQVIA Holdings to $270 From $290	MT
Dec. 02	Nephron Upgrades IQVIA Holdings to Buy, Price Target is $250	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HSBC Adjusts Price Target on IQVIA Holdings to $270 From $290	Dec. 04	MT
Nephron Upgrades IQVIA Holdings to Buy, Price Target is $250	Dec. 02	MT
Nephron Research Upgrades IQVIA to Buy, Price Target is $250	Dec. 02	MT
Goldman Sachs Adjusts Price Target on IQVIA Holdings to $230 From $250, Maintains Buy Rating	Nov. 26	MT
Redburn Atlantic Adjusts Price Target on IQVIA Holdings to $255 From $276, Maintains Buy Rating	Nov. 25	MT
Baird Adjusts Price Target on IQVIA Holdings to $213 From $223, Maintains Neutral Rating	Nov. 25	MT
Leerink Adjusts Price Target on IQVIA Holdings to $248 From $260, Maintains Outperform Rating	Nov. 19	MT
Argus Cuts Price Target on IQVIA to $260 From $280	Nov. 06	MT
JPMorgan Cuts Price Target on IQVIA to $240 From $279, Maintains Overweight Rating	Nov. 05	MT
UBS Adjusts Price Target on IQVIA to $260 From $300, Maintains Buy Rating	Nov. 01	MT
Citigroup Adjusts Price Target on IQVIA to $225 From $250	Nov. 01	MT
Jefferies Adjusts Price Target on IQVIA to $195 From $242	Nov. 01	MT
BTIG Adjusts Price Target on IQVIA to $260 From $290	Nov. 01	MT
Baird Adjusts Price Target on IQVIA to $223 From $256	Nov. 01	MT
Barclays Adjusts Price Target on IQVIA to $255 From $260	Nov. 01	MT
Goldman Sachs Adjusts Price Target on IQVIA to $250 From $280	Nov. 01	MT
Deutsche Bank Adjusts Price Target on IQVIA to $265 From $270	Nov. 01	MT
Evercore ISI Adjusts Price Target on IQVIA to $235 From $265	Nov. 01	MT
Leerink Partners Adjusts Price Target on IQVIA to $260 From $270	Nov. 01	MT
Stifel Adjusts Price Target on IQVIA to $273 From $312	Nov. 01	MT
TD Cowen Adjusts Price Target on IQVIA to $255 From $270	Nov. 01	MT
Truist Cuts Price Target on IQVIA Holdings to $265 From $286, Maintains Buy Rating	Nov. 01	MT
Analyst recommendations: Amazon.com, Mastercard, Bristol-Myers Squibb Company, Uber Technologies, Regeneron Pharmaceuticals...	Nov. 01
Deutsche Bank Trims Price Target on IQVIA Holdings to $265 From $270, Keeps Buy Rating	Nov. 01	MT
RBC Trims Price Target on IQVIA Holdings to $270 From $275, Keeps Outperform Rating	Oct. 29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Iqvia Holdings Inc.

Equities

IQV

US46266C1053

Biotechnology & Medical Research

Analyst Reco.

Filters